Terms: = Lung cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45
354 results:
1. Detection of fucosylated extracellular vesicles miR-4732-5p related to diagnosis of early lung adenocarcinoma by the electrochemical biosensor.
Zhu S; Chen J; Yu L; Li J; You S; Zheng Y; Zhuang W; Qiu B; Huang Y
Sci Rep; 2024 May; 14(1):11217. PubMed ID: 38755208
[TBL] [Abstract] [Full Text] [Related]
2. Abnormal expression of lca and CD43 in SCLC: a rare case report and brief literature review.
Cai Z; Zuo L; Hu F; You H; Lu X; Liao S; Liu F; Li L; Huang W
BMC Pulm Med; 2024 Apr; 24(1):195. PubMed ID: 38649942
[TBL] [Abstract] [Full Text] [Related]
3. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments.
Zhang Y; Hu Q; Pei Y; Luo H; Wang Z; Xu X; Zhang Q; Dai J; Wang Q; Fan Z; Fang Y; Ye M; Li B; Chen M; Xue Q; Zheng Q; Zhang S; Huang M; Zhang T; Gu J; Xiong Z
Nat Commun; 2024 Apr; 15(1):3382. PubMed ID: 38643164
[TBL] [Abstract] [Full Text] [Related]
4. Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation.
Sriraman N; Sarkar A; Naskar S; Mahajan N; Mukherjee O; Pradeep R; George M; Sarkar K
Med Oncol; 2024 Apr; 41(5):107. PubMed ID: 38580762
[TBL] [Abstract] [Full Text] [Related]
5. PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.
Schöne N; Kemper M; Menck K; Evers G; Krekeler C; Schulze AB; Lenz G; Wardelmann E; Binder C; Bleckmann A
J Extracell Vesicles; 2024 Mar; 13(3):e12418. PubMed ID: 38453684
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics and influencing factors of demoralization in patients with lung cancer: A latent class analysis.
Hong YT; Ye BQ; Lin JL; Chen QH; Zhang J; Chen WT; Huang FF
Psychooncology; 2024 Mar; 33(3):e6312. PubMed ID: 38429989
[TBL] [Abstract] [Full Text] [Related]
7. Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell lung cancer.
Rigamonti A; Viatore M; Polidori R; Rahal D; Erreni M; Fumagalli MR; Zanini D; Doni A; Putignano AR; Bossi P; Voulaz E; Alloisio M; Rossi S; Zucali PA; Santoro A; Balzano V; Nisticò P; Feuerhake F; Mantovani A; Locati M; Marchesi F
Cancer Res; 2024 Apr; 84(7):1165-1177. PubMed ID: 38315789
[TBL] [Abstract] [Full Text] [Related]
8. Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer.
Wang ZD; Feng YF; Wang YS; Ma Y; Liu J; Li D; Li S; Zhang GD
Thorac Cancer; 2024 Mar; 15(8):654-660. PubMed ID: 38297462
[TBL] [Abstract] [Full Text] [Related]
9. [Establishment of a 21-color Panel for the Detection of Immune Cell Subsets
in Human Non-small Cell lung cancer Tumor Tissues with Flow Cytometry].
Guo T; Xie H
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):56-64. PubMed ID: 38296626
[TBL] [Abstract] [Full Text] [Related]
10. Under the Microscope: A Case Report of Thoracic SMARCA4-Deficient Undifferentiated Tumor with Review of the Literature.
Mundada M; Mannan KA; Vasu D; Ahmed F; K S
Turk Patoloji Derg; 2024; 40(2):128-133. PubMed ID: 38265099
[TBL] [Abstract] [Full Text] [Related]
11. Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.
Mezquita L; Oulhen M; Aberlenc A; Deloger M; Aldea M; Honore A; Lecluse Y; Howarth K; Friboulet L; Besse B; Planchard D; Farace F
Br J Cancer; 2024 Mar; 130(4):682-693. PubMed ID: 38177660
[TBL] [Abstract] [Full Text] [Related]
12. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC).
Mukherjee O; Paul S; Das S; Rakshit S; Shanmugam G; George M; Sarkar K
Pathol Res Pract; 2024 Jan; 253():155004. PubMed ID: 38086291
[TBL] [Abstract] [Full Text] [Related]
13. Anterior mediastinal neuroblastoma in an adult: an additional case of a rare tumor in an unusual location with review of the literature.
Collins K; Ulbright TM; Davis JL
Diagn Pathol; 2023 Nov; 18(1):127. PubMed ID: 38031161
[TBL] [Abstract] [Full Text] [Related]
14. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
15. Cytomorphologic and immunocytochemical characterization of pediatric pleuropulmonary blastoma with a comprehensive review of the literature.
Gupta P; Chugh S; Gupta N; Gupta K; Sodhi KS; Kakkar N; Srinivasan R; Rohilla M; Kundu R; Trehan A; Bansal D; Peters NJ
Diagn Cytopathol; 2024 Feb; 52(2):103-115. PubMed ID: 37964698
[TBL] [Abstract] [Full Text] [Related]
16. Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype.
Vanhaver C; Aboubakar Nana F; Delhez N; Luyckx M; Hirsch T; Bayard A; Houbion C; Dauguet N; Brochier A; van der Bruggen P; Bruger AM
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37931958
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA MIR210HG promotes the proliferation, migration, and invasion of lung cancer cells by inhibiting the transcription of SH3GL3.
Zou F; Zhang ZH; Zou SS; Zhuang ZB; Ji Q; Chang R; Cao JH; Wang B
Kaohsiung J Med Sci; 2023 Dec; 39(12):1166-1177. PubMed ID: 37916731
[TBL] [Abstract] [Full Text] [Related]
18. A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma.
Luo W; Hoang H; Liao Y; Pan J; Ayello J; Cairo MS
Front Immunol; 2023; 14():1277987. PubMed ID: 37868989
[TBL] [Abstract] [Full Text] [Related]
19. Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.
Fan X; Guan G; Wang J; Jin M; Wang L; Duan X
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859622
[TBL] [Abstract] [Full Text] [Related]
20. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
Ikemoto S; Sakurai F; Tokuoka S; Yamashita T; Takayama K; Hoshi K; Okabe T; Sumiyoshi I; Togo S; Takahashi K; Tachibana M; Mizuguchi H
PLoS One; 2023; 18(10):e0286323. PubMed ID: 37856461
[TBL] [Abstract] [Full Text] [Related]
[Next]